LMI-070
LMI070 (NVS-SM1, Branaplam) is a potent SMN2 splice modulator (EC50=20 nM) that potential treatment of spinal muscular atrophy (SMA) .Spinal Muscular Atrophy (SMA), Phase 2 Clinical.
Product Specifications
CAS Number
1562338-42-4
Product Name Alternative
NVS-SM1 | Branaplam
Purity
>98% (HPLC)
Solubility
DMSO: 6.12 mg/mL
Smiles
CC1 (CC (CC (N1) (C) C) OC2=NN=C (C=C2) C3=C (C=C (C=C3) C4=CNN=C4) O) C
Molecular Formula
C22H27N5O2
Molecular Weight
393.4821
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Phenol, 5- (1H-pyrazol-4-yl) -2-[6-[ (2,2,6,6-tetramethyl-4-piperidinyl) oxy]-3-pyridazinyl]-
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![4-Oxo-3,4-dihydrothieno[3,2-d]pyrimidine-7-carboxylic acid](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
OR72979-01 100 mg
4-Oxo-3,4-dihydrothieno[3,2-d]pyrimidine-7-carboxylic acid
Sign In for Pricing
View Details OR72979-02 250 mg
4-Oxo-3,4-dihydrothieno[3,2-d]pyrimidine-7-carboxylic acid
Sign In for Pricing
View Details OR72979-03 1 g
4-Oxo-3,4-dihydrothieno[3,2-d]pyrimidine-7-carboxylic acid
Sign In for Pricing
View Details 